CONMED Corporation (CNMD) Stock
CONMED stock price chart
CNMD stock quote & key statistics
CONMED annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $1.37B | $47.1M | $4.61 |
| FY2024 | $1.31B | $132.4M | $4.16 |
| FY2023 | $1.24B | $64.5M | $3.45 |
| FY2022 | $1.05B | -$80.6M | $2.65 |
| FY2021 | $1.01B | $62.5M | $3.21 |
Fiscal year ending December 31. Source: company filings via EODHD.
About CONMED Corporation
CONMED Corporation is a prominent medical technology company renowned for its development, manufacturing, and global distribution of surgical devices and associated equipment. Specializing in orthopedic surgery, CONMED offers innovative products like the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These advanced solutions cater to orthopedic surgeons, facilitating the repair of soft tissue injuries and supporting minimally invasive sports medicine procedures. The company's orthopedic surgery portfolio includes well-known brands such as Hall, CONMED Linvatec, Concept, and Shutt.
In addition to orthopedics, CONMED excels in general surgery, providing a range of products essential for clinical insufflation, smoke evacuation, electrosurgical procedures, and endomechanical interventions. The company also specializes in endoscopic technologies, offering diagnostic and therapeutic solutions for gastroenterology procedures and treatments for biliary structure diseases. Its cardiac monitoring products, including ECG and EEG electrodes, and cardiac defibrillation pads, further demonstrate CONMED's commitment to comprehensive medical solutions.
CONMED markets its extensive product line directly to hospitals, surgical centers, and healthcare institutions worldwide. Collaborating with medical specialty distributors enhances its reach and ensures broad accessibility to its cutting-edge technologies. Founded in 1970 and headquartered in Largo, Florida, CONMED Corporation continues to innovate within the medical field, striving to improve patient outcomes and enhance surgical efficiency through continuous advancement in surgical technology and device solutions.
With a steadfast dedication to innovation and patient care, CONMED Corporation remains at the forefront of the medical technology industry, committed to meeting the evolving needs of surgeons and healthcare providers globally.
CONMED stock FAQ
What is the CONMED stock ticker symbol?
CONMED Corporation trades on the NYSE under the ticker symbol CNMD.
What sector and industry is CONMED in?
CONMED Corporation is classified in the Healthcare sector, Medical Devices industry.
How many employees does CONMED have?
CONMED Corporation has about 3,900 full-time employees.
What were CONMED's revenue and earnings last fiscal year?
CONMED reported revenue of $1.37B and net income of $47.1M in fiscal 2025, with earnings per share of $4.61. Revenue grew 5.2% from the prior year.
Is CONMED in the S&P SmallCap 600?
Yes. CONMED Corporation (CNMD) is a component of the S&P SmallCap 600, the benchmark index of profitable U.S. small-cap stocks.
Is CONMED in the Russell 2000?
Yes. CONMED Corporation (CNMD) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did CONMED go public?
CONMED stock began trading on July 23, 1987.
S&P SmallCap 600 Medical Devices stocks
All S&P SmallCap 600 →- AHCOAdaptHealth
- ALKSAlkermes
- AORTArtivion
- CONConcentra Group Holdings Parent
- ENOVEnovis
- GKOSGlaukos
- IARTIntegra LifeSciences
- ICUIICU Medical
- INDVIndivior
- INSPInspire Medical Systems
- ITGRInteger
- LGNDLigand Pharmaceuticals
- MMSIMerit Medical Systems
- NEOGNeogen
- OGNOrganon
- PTCTPTC Therapeutics
- PTGXProtagonist Therapeutics
- QDELQuidelOrtho
- RDNTRadNet
- TFXTeleflex
- TGTXTG Therapeutics
- TMDXTransMedics
- TNDMTandem Diabetes Care
- UFPTUFP Technologies